Medial temporal atrophy as a magnetic resonance imaging marker for Alzheimer's disease.
Medial temporal lobe atrophy (MTLA) on brain magnetic resonance imaging (MRI) may help differentiate Alzheimer's disease (AD) from multiinfarct dementia (MID) and other dementias.  MTLA was seen in 6 of 11 patients with clinically diagnosed AD, 16 of 20 with mixed dementia (with both AD and MID), 1 of 5 with psychiatric disease, and in none of 32 with MID or 8 with other dementias (p less than 0.0001). Increased patchy periventricular signal, or "unidentified bright objects" were seen in 2 of 11 patients with AD, 10 of 20 patients with AD and MID, and 26 of 32 patients with MID.  A larger series with autopsy correlation may verify that MTLA is a reasonably specific marker for AD, and unidentified bright objects are a sensitive, but not specific, marker for vascular dementias.
Barclay
L L
LL
Department of Neurology, University of South Florida Health Sciences Center, Tampa 33612.
Linden
C
C
Murtagh
R
R
D000368:Aged; D000544:Alzheimer Disease / Q000175:diagnosis* / Q000473:pathology; D015140:Dementia, Vascular / Q000175:diagnosis*; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008297:Male; D012680:Sensitivity and Specificity; D013702:Temporal Lobe / Q000473:pathology*